AbbVie and Iambic, a clinical-stage life sciences and technology company developing novel medicines through its AI-driven discovery and development platform,announced a multi-year collaboration to accelerate the discovery and development of small molecule therapies with first-in-class and best-in-class potential acros…
mAbxience, a majority-owned company of Fresenius with partial ownership from Insud Pharma; and Sandoz , the global leader in affordable medicines, announced a licensing, development, manufacturing and commercialization agreement for an emicizumab biosimilar candidate. The collaboration agreement combines mAbxience's …
Telix Pharmaceuticals Limited announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE, a global leader in radioisotope production and radiopharmaceutical development. The merger will further strengthen Telix's leadership as a vertically integrated radiopharmaceutical com…
Jazz Pharmaceuticals plc announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. Jazz completed the acquisition of Actio Biosciences through the merger of Knight Acquisition Corp. (the "Merger Sub"), a D…
Jaguar LAA, Inc, a privately held medical device company announced the acquisition of assets related to the Laminar program, focused on addressing the left atrial appendage in patients with non-valvular atrial fibrillation ("AFib"), from Johnson & Johnson. The transaction brings key Laminar program assets togethe…
Novo Holdings, a leading global healthcare and life sciences investor, announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd., a China-based contract development and manufacturing organisation (CDMO) specialising in advanced wound care products. GL Capital, one of China's leading health…
Labcorp a global leader of innovative and comprehensive laboratory services, announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed. The ac…
Invagen Pharmaceuticals Inc, a wholly owned subsidiary of Cipla Limited announced that it has entered into a strategic partnership with Qilu Pharmaceutical Co., Ltd. (hereinafter referred to as Qilu), for the exclusive licensing and supply of QL2107, a biosimilar to Keytruda® (pembrolizumab), for the United States As…
Medtronic, a global leader in healthcare technology, announced a strategic partnership with Cornerstone Robotics, an innovative surgical robotics company committed to advancing minimally invasive surgery and improving access to the latest surgical care worldwide. The approximately $700 million investment includes righ…
Monash Health, the largest public health service in Victoria, Australia, has signed a Memorandum of Understanding (MoU) with Data4Life, an international nonprofit digital health organization funded by the Hasso Plattner Foundation. The announcement was made by Associate Professor Tam C. Nguyen, Director of Research &a…
Page 3 of 41